Yuto Kubo

National Cancer Center Hospital East

Papers

3

Total Citations

13

H-Index

2

About

Dr. Yuto Kubo is a pioneering surgeon advancing the field of minimally invasive esophageal oncology, with a focused expertise in robotic esophagectomy for locally advanced esophageal cancer. His major contributions center on demonstrating the technical feasibility and oncological safety of robotic approaches—particularly for challenging clinical T3 and T4 tumors, which are often deemed borderline or unresectable. In his landmark 2024 propensity-matched analysis (10 citations), Dr. Kubo showed that robotic esophagectomy yields comparable or superior short-term outcomes to conventional thoracoscopic techniques, even for highly advanced stage cT3 borderline and cT4b disease. His subsequent 2025 work (2 citations) further validates these findings, while his pioneering investigation into robot-assisted transcervical esophagectomy (1 citation) explores a novel, less invasive access route for thoracic esophageal carcinoma. Through these studies, Dr. Kubo is reshaping surgical paradigms, offering patients with aggressive, locally advanced tumors a viable, minimally invasive alternative that reduces morbidity without compromising oncologic outcomes. His research is instrumental for surgeons and trainees seeking to expand the boundaries of robotic esophageal surgery.

Research Focus

Key Achievements

2
H-Index
3
Papers
13
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Technical feasibility and oncological outcomes of robotic esophagectomy compared with conventional thoracoscopic esophagectomy for clinical T3 or T4 locally advanced esophageal cancer: a propensity-matched analysis
10 citations · 2024
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: National Cancer Center Hospital East

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago